Halozyme Therapeutics wants to take over Evotec. The US biopharmaceutical company based in San Diego is offering €2 billion for the German drug developer.
Ambiopharm, a US-based pharmaceutical services company specializing in peptide manufacturing, recently announced the groundbreaking of a 70,000-square-foot (6,504 m2)...
US drugmaker Merck & Co. (MSD) has entered into a global license agreement to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific...
Foodgrade phosphoric acid is currently a new product from the Elixir Group that is in demand in Europe and beyond. The Serbian group of companies has commenced production...
BioNTech and Biotheus recently announced the signing of a definitive agreement for the acquisition of Biotheus, a clinical-stage biotechnology company dedicated to the...
Anglo-Swedish drugmaker AstraZeneca plans to invest $3.5 billion in the US to expand the company’s research and manufacturing footprint by the end of 2026.
Dinamiqs, a company specializing in the development and production of viral vectors and part of the Swiss Siegfried Group since May 2023, has inaugurated its new research...
